Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Rotigotine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 13,273Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    UCB's second shot at Neupro patent validation fails on appeal
    UCB's second shot at Neupro patent validation fails on appeal

    13 Apr 2023

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/pharma/appeals-court-shoots-down-ucbs-neupro-patch-patent-allowing-actavis-and-mylan-generics

    Nick Paul Taylor FIERCE PHARMA
    13 Apr 2023
    Share Share
    XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson
    XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson

    18 Oct 2022

    // ACCESSWIRE

    https://www.accesswire.com/720788/XPhyto-Reports-Excellent-Rotigotine-In-VitroEx-Vivo-Results-for-Parkinsons-Disease-Treatment

    ACCESSWIRE
    18 Oct 2022
    Share Share
    XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD
    XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD

    09 May 2022

    // ACCESSWIRE

    https://www.accesswire.com/700572/XPhyto-Reports-Product-Developments-on-Platform-Based-Rotigotine-Transdermal-Patch-for-Parkinsons-Disease

    ACCESSWIRE
    09 May 2022
    Share Share
    XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD
    XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD

    04 Apr 2022

    // ACCESSWIRE

    https://www.accesswire.com/695803/XPhyto-Reports-Market-and-Product-Developments-on-Platform-based-Rotigotine-Transdermal-Patch-for-Parkinsons-Disease

    ACCESSWIRE
    04 Apr 2022
    Share Share
    XPhyto Reports Development Update for its Drug Delivery Business
    XPhyto Reports Development Update for its Drug Delivery Business

    12 Oct 2021

    // ACCESSWIRE

    https://www.accesswire.com/667674/XPhyto-Reports-Development-Update-for-its-Drug-Delivery-Business

    ACCESSWIRE
    12 Oct 2021
    Share Share
    Letters and drug alerts sent to healthcare professionals in July 2019
    Letters and drug alerts sent to healthcare professionals in July 2019

    19 Aug 2019

    // GOVUK

    https://www.gov.uk/drug-safety-update/letters-and-drug-alerts-sent-to-healthcare-professionals-in-july-2019

    GOVUK
    19 Aug 2019
    Share Share